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Essential fructosuria Is one of the oldest known inborn
errors of metabolism. It Is a benign condition which is
believed to result from deficiency of hepatic fructo-
kinase (ketohexokinase, KHK, E.C.2.7.1.3). This
enzyme catalyses the first step of metabolism of
dietary fructose, conversion of fructose to fructose-
1-phosphate. Despite the early recognition of this
disorder, the primary structure of human KHK and the
molecular basis of essential fructosuria have not been
previously defined. In this report, the isolation and
sequencing of full-length cDNA clones encoding human
ketohexokinase are described. Alternative mRNA
species and alternative KHK isozymes are produced by
alternative polyadenylation and splicing of the KHK
gene. The KHK proteins show a high level of sequence
conservation relative to rat KHK. Direct evidence that
mutation of the KHK structural gene Is the cause of
essential fructosuria was also obtained. In a well-
characterized family, in which three of eight siblings
have fructosuria, all affected individuals are compound
heterozygotes for two mutations Gly40Arg and
Ala43Thr. Both mutations result from G - A transitions,
and each alters the same conserved region of the KHK
protein. Neither mutation was seen In a sample of 52
unrelated control individuals. An additional conserva-
tive amlno acid change (Val49lle) was present on the
KHK allele bearing Ala43Thr.
INTRODUCTION
In mammals, dietary fructose is primarily metabolized through
a pathway distinct from that responsible for glucose metabolism.
This pathway utilizes three specialized enzymes, fructokinase
(ketohexokinase, KHK, EC 2.7.1.3), aldolase B (fructose-1-
phosphate aldolase, EC 4.1.2.13) and triokinase (EC 2.7.1.28),
which convert fructose into intermediates of the glycolytic and
gluconeogenic pathways. KHK is found predominandy in liver,
kidney, and small intestine, and catalyses the conversion of
fructose to fructose-1-phosphate. It is also active using other
ketose sugars as substrate (for review, see ref. 1).
Human KHK has been purified from liver, to a specific activity
which suggests it constitutes about 0.07% of liver protein (2).
Both the human and bovine enzymes appear to be dimers (2,3),
with an estimated subunit molecular weight of 39 000. Human
KHK has an apparent Knj for fructose of 0.86 mM (2); its high
V^j allows very rapid metabolism of dietary fructose via the
specialized fructose pathway, which bypasses die usual major
site of glycolytic regulation (phosphofructokinase). After
parenteral fructose administration, this can result in severe lactic
acidosis even in normal individuals (for review, see ref. 1).
Essential fructosuria (MIM number 229800), although not one
of the four disorders discussed by Garrod, can claim to be one
of the earliest described inborn errors of metabolism, having been
first recognized almost 120 years ago. It is a benign condition
characterized by the intermittent appearance of fructose in the
urine. In affected subjects, ingestion of dietary fructose, sucrose
or sorbitol is followed by an abnormally large and persistent rise
in blood fructose concentration, and by excretion of 10-20%
of the ingested load in the urine (1). Essential fructosuria appears
to be inherited as an autosomal recessive trait (see Discussion).
In one affected individual an indirect enzyme assay was used to
demonstrate a deficiency of hepatic fructokinase (4), but the
molecular basis for essential fructosuria has remained otherwise
undefined.
No molecular genetic studies of human KHK have been
previously undertaken. The primary structure of rat liver KHK
was, however, recendy described (5). This work demonstrated
that KHK is structurally unlike other mammalian hexokinases,
and does not show significant homology with other known
mammalian protein families. However, short sequence motifs
shared with some bacterial phosphotransferases, which like KHK
have a furanose sugar substrate, did suggest the possibility of
an ancestral furanose kinase, from which these proteins evolved.
RESULTS
Isolation of human KHK cDNA clones
Since no other information was available, as to which residues
of KHK might be conserved between mammals, we chose to
screen for human KHK by low-stringency hybridization with the
entire rat KHK coding region, rather than by polymerase chain
reaction (PCR) with degenerate oligonucleotide pools. Three
cDNA clones > 1 kb in size, isolated in this way from a cDNA
library of the hepatoblastoma cell HepG2, were completely
sequenced. The nucleotide sequence and translated open reading
frame of the longest of these (pHKHK3a) are shown in Figure
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Figure 1. The sequence of KHK cDNA. The sequence of the longest clone
(pHKHK3a) is shown. The shorter clones pHKHK3d and pHKHKl-2 lie within
this sequence; their 5' limits are indicated by I and 0 , respectively. Both of
these shorter clones end at the upstream polyadenylation site indicated by *. The
consensus and variant polyadenylation signals are underlined. The alternatively
spliced exon (C) encoded in clone pHKHKl-2 is shown in italics below the main
sequence. This exon corresponds closely to the sequence of the rat KHK cDNA
(5; see also Figure 2). Matching residues between the two alternative splice forms
of human KHK are underlined. The precise limits of the alternatively spliced
exon cannot be stated at present since genomic clones have yet to be analysed.
The Gly40Arg and Ala43Thr changes are caused by the mutations indicated in
bold type at nt 126 and 143. The other sequence variants observed are also indicated
in the same way. Argl59Gly was found only in clone pHKHK3d, and it is unclear
at present whether it represents a cloning artefact or a true polymorphic variant.
The nucleotide sequence data reported in this paper will appear in the EMBL,
GenBank and DOBJ Nucleotide Sequence Databases under the accession numbers
X78677 and X78678.
1. The positions of the sequence variants detected in other clones
(discussed below) are also shown.
Alternative splicing and polyadenylation
The most notable feature of pHKHK3a is its long (984 nt) 3'
untranslated region. This is in contrast to the 186 nt 3'
untranslated region of the published rat KHK mRNA. The other
two human clones (pHKHK3d, pHKHKl-2), however, are
derived from mRNA which has utilized an upstream
polyadenylation site, closer to the position of that in the rat (giving
a 3' untranslated region of 218 nt).
The sequences of pHKHK3a, pHKHK3d and pHKHKl-2 are
collinear except for nt 218 to 352 in Figure 1. Here, pHKHKl-2
differs over its first 140 bp from the sequence of the other two
clones. This appears to result from alternative splicing to include
either of two exons. The published rat cDNA sequence (5)
corresponds in this region to the splice variant found in
pHKHKl-2, referred to subsequently as form C. The other splice
variant is referred to below as form A. Closer inspection (Figure
1) shows that these two alternatively spliced exons can be aligned
with each other to reveal conservation of several amino acid
residues. This suggests that an intragenic duplication event may
have given rise to the alternative exons in this region of the KHK
gene.
The predicted molecular weight of the human KHK A subunit
is 32 734. The initiator ATG shown in Figure 1 is presumptive,
since no in-frame upstream stop codon is present in the clones.
However, this assignment is based on the position of the initiator
codon in the rat mRNA (5) which was verified by the agreement
of the predicted protein Mr with the Mr directly determined by
mass spectrometry.
A single amino acid variant was found among the three
independent HepG2 KHK cDNA clones. Argl59 is altered to
Gly by an A—G transition in clone pHKHK3d. The alignment
in Figure 2 shows that unlike the two residues mutated in essential
fructosuria patients (see below) Argl59 is not conserved
between human and rat, and indeed lies at the centre of the most
poorly conserved region of KHK.
Tissue distribution of KHK mRNA
KHK activity is found principally in liver, kidney, and small
intestine (2); pancreatic islet cells also possess a similar activity
(6). Because of this tissue specificity, it was initially unclear
whedier analysis of KHK RNA in patients with essential
fructosuria would be possible. To investigate this, reverse
transcription and PCR (RT-PCR) of the 5' coding region (nt
1 -410, primers KHK1/KHK3) were performed on RNA from
human fetal tissues. As expected, strong signals were obtained
from liver, kidney, gut and pancreas, as well as (unexpectedly)
from spleen. However, we were encouraged to find lower yields
of PCR product also from adrenal, muscle, brain and eye, as
well as from human diploid fibroblasts and from an EBV-
transformed lymphoblastoid cell line (data not shown). This may
be in keeping with previous observations of low level KHK
activity in some other tissues (2).
Mutations causing essential fructosuria
Next, we investigated the postulate that mutation of the human
KK gene underlies the rare metabolic disorder, essential
fructosuria. The family analysed has been the subject of previous
metabolic studies which have demonstrated excessive
fructosaemia and fructosuria after oral or intravenous fructose,
sorbitol, or sucrose (7—9). After an intravenous fructose bolus
(200 mg/kg) the liver concentrations of fructose-1-phosphate,
ATP, and phosphate, as determined by 31P magnetic resonance
spectroscopy in one affected family member (RK), remained
unchanged, in contrast to controls, confirming that fructokinase
was indeed inactive (10,11). In this Swiss family, three of eight
siblings have fructosuria. Since the parents are third degree
cousins, it was anticipated that homozygosity for a single mutation
would underlie the fructosuria. As the intron-exon structure of
KHK remains to be defined, analysis of genomic DNA is difficult.
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Figure 2. Alignment of rat and human KHK amino acid sequences. The human A form is shown above the rat (middle line) and the human C form beneath it
(partial sequence only, the 3' region being identical to the A form). The positions of the human sequence variants Gly40Arg, Ala43Thr, Val49He (found in the
essential fructosuria family) and of Argl59Gly (found in clone pHKHK3d) are indicated by bold type and by o above the human sequence. It can be seen that
whereas the region containing Gly40, Ala43 and Val49 is well conserved, Argl59 lies within the most poorly conserved region of the protein. The residues in italics
in the human sequences indicate the minimum extent of the alternatively spliced exons. Identical residues are indicated by | between adjacent residues, and conservative
or semi-conservative substitutions by : and . , respectively.
However, the finding of KHK mRNA in lymphoblastoid cells
suggested the feasibility of analysing RNA. Therefore, RT-PCR
of RNA from a lymphoblastoid cell line from one patient (AK)
was performed, amplifying the coding region in two overlapping
segments. The PCR products were cloned into the
pCRScriptSK+ plasmid vector (Stratagene, Inc.) and single
overlapping clones were sequenced. The sequence of the entire
coding region thus obtained revealed two single-base
substitutions. The first, A—G at nt 587, is a silent change at
the third base of Lysl93. The other, G—A at nt 126, changes
the Gly40 codon to Arg. This mutation has occurred at a CpG
dinucleotide, within a well-conserved region (Figure 2); it
destroys a BstUl site (CGCG) at nt 123-126.
A PCR assay on genomic DNA was then used to analyse for
the nt 126 G—A change in a sample of 52 normal individuals.
None contained the putative mutation, which is therefore unlikely
to be a normal polymorphic variant. Next, the same assay was
used to type all 10 members of the fructosuria family, by BstUl
digestion of the 94 bp PCR product (Figure 3a). Surprisingly,
this showed that the three fructosuric individuals were
heterozygous for Gly40Arg, inherited from their mother. The
initial supposition of homozygosity by descent for a single
mutation in this consanguineous family was therefore erroneous.
Fortuitously though, the other BstUl site predicted in the PCR
product (at nt 134-137) was found to be absent from one allele
in the father in this family (Figure 3a, lane 1). All three
fructosuric patients had also inherited this second sequence variant
(Figure 3a, lanes 6, 8, 9). Since the BstUl site at 134-137 is
also part of an Mlul site (ACGCGT), this second mutation was
more clearly demonstrated by Mlul digestion of the PCR product
(Figure 3b). To define the exact nature of the second mutation,
the 94 bp product was digested with Mlul and the A/M-resistant
94 bp fraction cloned and sequenced. This revealed two further
G—A changes, at nt 135 and 153. The first of these causes the
non-conservative substitution Ala43Thr and the second the
conservative change Val49Ile. Like Gly40Arg, the Ala43Thr
mutation was not observed in any of the 52 control DNA samples
analysed by BstUl digestion, and hence is unlikely to be a
polymorphic variant. Separate analysis of the Val49De substitution
showed the father in this family to be homozygous for De49 and
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Figure 3. DNA analysis of a family with essential fructosuria. On the pedigree,
KHK mutations are indicated by shading of the right (Gly40Arg) or left (Ala43Thr)
half of the symbol, (a) 21 % polyacrylamide minigel showing ethidium bromide-
stained BstUl digests of a 94 bp PCR product (KHK14-KHK15) containing the
Gly40Arg and Ala43Thr mutation sites. The grey arrow to the right indicates
the position of undigested product (not present on this gel) and of the uncut
heteroduplex bands in the affected individuals in lanes 6, 8 and 9. To the left,
white arrows indicate the normal digestion products (62, 21 and 11 (not seen)
bp) and black arrows the fragments of increased size resulting from loss of one
or other BstUl site (32 bp for Gly40Arg, 73 bp for Ala43Thr). (b) Fifteen percent
polyacrylamide minigel showing ethidium bromide-stained Mlul digests of the
same PCR products. The normal digestion products (white arrows) are 62 and
32 bp, the Ala43Thr mutation prevents cleavage (94 bp, black arrow). The faint
94 bp bands in lanes 7 and 10 are due to incomplete Mlul digestion, which is
difficult to overcome with this small fragment. O = origin.
the mother homozygous for Val49 (not shown). Thus a total of
four KHK haplotypes can be defined within the family; Gly40
Ala43 De49 (normal paternal haplotype), Gly40 Ala43 Val49
(normal maternal haplotype), Gly40 Thr43 De49 (mutant paternal
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haplotype) and Arg40 Ala43 Val49 (mutant maternal haplotype).
All six possible combinations of the four haplotypes are seen in
the family, but only Gly40 Thr43 De49/Arg40 Ala43 Val49
results in fructosuria.
DISCUSSION
In this report, we demonstrate that KHK structural gene defects
underlie essential fructosuria. The family analysed has been the
subject of previous metabolic studies (7 — 11). However, because
of the tissue specificity of KHK expression, deficiency of hepatic
KHK appears only to have been proven in one fructosuric
individual, by enzyme assay on a liver biopsy (4). Essential
fructosuria is certainly rare. Lasker estimated its incidence at less
than 1 in 130 000, but plausibly suggested this was an
overestimate (12). In four of her five families there was parental
consanguinity, and the proportion of such families was used to
suggest a true frequency nearer one in a million, as well as to
support autosomal recessive inheritance. We were surprised, in
light of this, to find that in the family we report here the parental
consanguinity appears to be coincidental, with the affected
individuals being compound heterozygotes for the mutations
Gly40Arg and Ala43Thr.
Since two amino acid substitutions were found together on the
paternal KHK allele in our family, we cannot be completely
confident that Ala43Thr alone (in the absence of Val49De) is a
null mutation. To prove this would require introduction of each
change separately into the normal KHK sequence by in vitro
mutagenesis and expression. Furthermore, to prove absolutely
that Gly40Arg or Ala43Thr are null mutations would require the
expression of each mutation in the context of each of the two
(A and C) splice variants. None the less, several lines of evidence
suggest that Gly40Arg and Ala43Thr are indeed responsible for
the fructosuric phenotype. They lie in a conserved region of the
protein, produce non-conservative amino acid changes, and are
not present in > 100 control alleles. Val49De, on the other hand,
does not produce fructosuria when present in the homozygous
state, and is a common polymorphism in normal Europeans (data
not shown). Finally, under the rather unlikely null hypothesis
that essential fructosuria could result from a mutation unlinked
to KHK, the concordant segregation between the mutations and
the fructosuria in this family has a probability of only (U)2 (K)5
(excluding one proband) » 1 in 67.
The most important new finding from these studies of human
KHK is that of alternative splicing, due to inclusion of one or
other of two similar exons, which we presume arose by an
intragenic duplication, though clarification of this must await
analysis of genomic KHK clones. It is not known at present
whether both splice forms of human KHK are enzymatically
active. However, the rat cDNA, which is known to be active
when expressed in isolation (13), is close in sequence to the
human C form, suggesting strongly that the latter at least will
encode a functional enzyme. Since both the human and bovine
KHK appear to be dimers in their native state, at least three
different KHK isozymes (A-A, A-C and C-C) could exist in vivo.
Both mutations we have identified lie in a conserved region,
common to both KHK splice forms, so that each could potentially
ablate function of all KHK isozymes.
KHK is believed to be synthesized largely in liver, renal cortex,
and small intestine, but one previous report also demonstrated
KHK-like activity in pancreas (6). Our preliminary RT-PCR
experiments are not quantitative but tend to confirm these
observations at the RNA level. The distribution of different KHK
splice forms in individual tissues requires analysis by RNase
protection, and is currently under study. However, preliminary
RT-PCR data suggest that the C-type mRNA may be confined
to those tissues expressing KHK at high level (liver, kidney, gut,
pancreas). It is interesting to note that the gene for glucokinase,
another hexokinase displaying a restricted tissue distribution
which includes liver and pancreatic islet cell, is subject to cell-
type specific alternative splicing in both humans and rat (14,15).
Characterization of the details of KHK alternative splicing and
tissue-specific promoter function await the isolation of KHK
genomic clones.
It is uncertain whether the rat KHK gene is also alternatively
spliced. However, the considerable divergence between human
A and C exons, compared with the close similarity between rat
and human C exons, suggests that the duplication which produced
the alternative exons is ancient, and pre-dated the divergence of
rodent and primate lineages.
MATERIALS AND METHODS
Isolation of human KHK cDNA dones
The rat liver KHK cDNA construct pUC-KHK-G7 (5) was digested with Bgta
to excise a 0.9 kb coding region fragment, which was labelled by random priming
and used to screen a library (constructed by Dr D.Simmonds, Oxford University)
of HepG2 (hepatoblastoma cell line) cDNA in the vector pCDM8 (16), propagated
on the supF-selecting strain MC1O61/P3. Final washing conditions for the cross-
species hybridization were: 6XSSC, 0.1% SDS. Screening of 50 000 colonies
yielded 13 positive clones, of which three (pHKHK3a, pHKHK3d and pHKHKl-2;
insert sizes 2.0, 1.15 and 1.1 kb) were completely sequenced directly on double-
stranded templates, using synthetic internal or flanking primers.
Cell culture and RT-PCR
Lymphoblastoid cells were grown in RPMI164O medium, with 10% fetal calf
serum, 2 mM L-glutamine, and 25 /jg/ml gentamicin. Total cell RNA was prepared
by the AGPC method (17). Reverse-transcription of 1 /ig total RNA was performed
for 1 h at 37°C in a 30 /U reaction mixture containing random hexadeoxynucleotide
primers, 10 mM TrisHCl, pH 8.3, 50 mM KC1, 6.5 mM MgCl2, 10 mM
dhnkxhreitol, 1 mM each dNTP, 15 U MuLV reverse transcriptase (BRL-Gibco).
For PCR, 15 (J of cDNA synthesis reaction mixture was added directly to 35 /d
RT-PCR mix (10 mM TrisHCl pH 8.3, 50 mM KC1, 1.5 mM MgCl2, 285
nM each PCR primer, 1 mM EDTA, 2U recombinant Taq polymerase). The
KHK coding region was amplified in two overlapping segments using primer pairs
KHKl/KHK3andKHK2/KHKll. In each case, 40 cycles of 1, I ,2minat94,
63, 72 °C were performed in a Perkin-Elmer Cetus Thermal Cycler. Products
were gel-purified prior to cloning.
Genomic DNA analysis
Genomic DNA was isolated from frozen whole EDTA-blood by Triton X-100
lysis and proteinase K digestion (18). For typing of the Gly40Arg and Ala43Thr
mutations, primers KHK14 and KHK15 were used for 30 cycles of PCR under
conditions as above except for a 60°C annealing temperature. The 94 bp product
is cleaved by firrtJl (CGCG) to 21 + 11 + 62 bp (Gly40 Ala43), to 32 + 62
bp (Arg40 Ala43) or to 21 + 73 bp (Gly40 Thr43). The small size of the PCR
product was dictated by the apparent positions of splice junctions and the unknown
genomic sequence flanking the exons, and by the proximity of the two flnUI
sites. The BstXJl digestion products were analysed on 21 % polyacrylamide gels.
Oligonucleotide sequences
KHK1: GTAGCCTCATGGAAGAGAAGC; KHK2: GTGTCTGCTACAGA-
CTTTGAG; KHK3: CTTGAACTGGGTCAGATCAAC; KHK11: AGC-
TTGCATCTGTCCCCTGAA; KHK14: TTTGTCCCAGAGATGGCAGCG;
KHK15: CATTGAGCCCATGAAGGC.
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ABBREVIATIONS
KHK, ketohexokinase; K,,,, Michaelis constant; MIM, Mendeiian Inheritance in
Man; M,, relative molecular mass; PCR, polymerase chain reaction; SDS,
sodium dodecyl sulphate; SSC, sah/sodium citrate (0.15 M NaCl, 15 mM sodium
citrate, pH 7.0).
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